Clinical Microbiology and Infection

Article	Citations
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review	706
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections	576
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)	389
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?	388
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value	382
Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing	302
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021	269
COVID-19 in special populations	241
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing	187
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition	178
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi	163
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?	156
Corrigendum to “Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations” [Clin Microbiol and Infect 26 (1) (2020) 60–70]	152
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections	151
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20	143
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study	138
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia	137
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness	129
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models	128
Outside Front Cover	124
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?	112
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?	107
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	105
Exploring the limits of interferon-γ releasing assay screening in large-scale populations	104
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use	104

Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)	102
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response	99
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern	98
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain	93
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate	89
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays	88
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	88
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples	86
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	86
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation	85
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023	83
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	83
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis	78
PRAISE: providing a roadmap for automated infection surveillance in Europe	78
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study	76
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments	75
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	74
Re: ‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’ by Kim et al.	72
Diagnostic accuracy of self-collected tongue swabs for Mycobacterium tuberculosis complex detection in individuals being assessed for tuberculosis in South Africa using the Xpert MTB/RIF Ultra assay	72
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia	71
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection	68
Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission	67
Effect of antiseptic bathing with chlorhexidine or octenidine on central line–associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial	66
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia	65
Inferring antibiotic susceptibility from metagenomic data: dream or reality?	63
Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019–2023	62
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19	61
Fulminant cytokine release syndrome in a paediatric patient with refractory Epstein–Barr virus-associated haemophagocytic lymphohistiocytosis receiving nivolumab treatment	58
A chronic infectious bladder stone causing an obstructive emphysematous cystitis	58
Accuracy of cholera rapid diagnostic tests: a systematic review and meta-analysis	57
In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection	57
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies	57
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values	56
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients	55
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study	55
One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis	54
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial	54
Aortic 18F-FDG PET/CT hypermetabolism in patients with long COVID: a retrospective study	53
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?	53
The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid	53
Risk factors of community-onset extended-spectrum β-lactamase Escherichia coli and Klebsiella pneumoniae bacteraemia: an 11-year population-based case–control–control study in Denmark	53
Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns	53
Effect of a multimodal prevention strategy on dialysis-associated infection events in outpatients receiving haemodialysis: The DIPS stepped wedge, cluster-randomized trial	52
Nursing practice is associated with high risk for hepatitis C virus infection	52
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply	52
Concurrent systemic antibiotics at catheter insertion and intravascular catheter-related infection in the ICU: a post hoc analysis using individual data from five large RCTs	52
A strain uncoloured by Gram staining in a pleural fluid	52
Steroids for viral meningitis: a foe or a friend?	51
Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model	50
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women	50

Assessing prescription of antibiotics after vaccination against pneumococcal pneumonia; using prescription sequence symmetry analysis	49
The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?	49
Removal of incorrect penicillin allergy labels in a UK hospital	49
Alternative therapies against Mycobacterium abscessus infections	48
The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort	48
A comparative evaluation of commercial boric acid containers for preserving microorganisms in urine specimens	47
The controversial bond between COVID-19 and bacterial superinfections	46
Community adoption of protective behaviours: before and during the COVID-19 pandemic	46
Which trials do we need?	46
Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study	45
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents	45
Remdesivir for the treatment of COVID-19: author's response	44
Kinetics of the Alethia® malaria loop-mediated isothermal amplification (LAMP) positivity during post-treatment follow-up of patients with imported malaria	44
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial	44
A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection	44
Seeing is Believing	43
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa	43
Scope and aims of European society of clinical microbiology and infectious diseases guidelines: a white paper	43
Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up	43
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China	43
Clinical microbiology laboratories in low-resource settings, it is not only about equipment and reagents, but also good governance for sustainability	43
Decision letters from other journals	42
Revisiting diagnostics: practical application of next-generation sequencing technologies for infectious diseases	42
Are we enrolling the right patients? A scoping review of external validity and generalizability of clinical trials in bloodstream infections	42
Optimization of antiviral dosing in Herpesviridae encephalitis: a promising approach to improve outcome?	42
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort	41
CMI: how did we do in 2020?	41
Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines	41
How to use direct microscopy for diagnosing fungal infections	40
Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study	40
Predictors of laboratory-confirmed mpox in people with mpox-like illness	40
Using a difficult-to-treat resistance index to gauge imbalance between countries' antibiotic resistance prevalence and access to antibiotics: a scoping review and concept proposal	40
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam vs. meropenem treatment: a propensity-matched cohort study	40
The interface between COVID-19 and bacterial healthcare-associated infections	39
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	39
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	39
Re: ‘ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults’ by Bodilsen et al.	39
Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates	38
Availability and costs of medicines for the treatment of tuberculosis in Europe	38
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort	38
Performances of NeuMoDx™, a random-access system for hepatitis B virus DNA and hepatitis C virus RNA quantification	37
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease	37
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024	37
A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages	37
Late positivization of oropharyngeal, plasma, anal, semen, and urine specimens which tested negative at the time of mpox diagnosis	37
Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic	37
Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations	36
An overview of COVID-19 in solid organ transplantation	36
Lyme neuroborreliosis with encephalitis; a systematic literature review and a Scandinavian cohort study	36
Blood culture bottles remain efficient months after their expiration date: implications for low- and middle-income countries	36
Why don't we talk about tuberculosis stewardship?	36
Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis	36
Exploring the dynamics of Borrelia burgdorferi sensu lato antibodies—a registry-based study on laboratory data from Sweden and Denmark	36
Antimicrobials are effective for treatment of uncomplicated urinary infection	36
‘Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA COVID-19 vaccine compared to unexposed infants’ – author's response	36
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned	35
High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: a prospective multisite cross-sectional study (ANRS COV11)	35
Real-life validation of a sample pooling strategy for screening of hepatitis C	35
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply	35
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection	35
Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States	35
Changing face of mpox	34
Quo vadis clinical diagnostic microbiology?	33
Early switch to oral antimicrobials in brain abscess: a narrative review	33
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group	33
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance	33
Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic	33
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!	33
Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settin	33
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	32
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19	32
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard	32
Diagnostic test accuracy of the Fungitell serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	32
Re: predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19	31
Re: ‘Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland’ by Garzoni et al.	31
Integrating pre-test probability and β-D-glucan cut-offs to enhance accuracy in diagnosing pneumocystis pneumonia	31
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury	31
Establishing piperacillin–tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurement	31
‘Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies’ – Author's reply	31
The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study	31

Unneeded antibiotics for acute respiratory infections in primary care: stop as early as possible	31
Variability of antibiograms: how often do changes in the antimicrobial susceptibility pattern occur in isolates from one patient?	30
Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation	30
Escherichia coli community-acquired meningitis in adults: a case series of 29 patients in France	30
Long-term evolution of humoral immune response after SARS-CoV-2 infection	30
First-generation oral antivirals against SARS-CoV-2	30
Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden	30
‘High prevalence of heterotopic ossification in critically ill patients with severe COVID-19’ – Author's reply	30
Determining the effect of pneumococcal vaccination on antibiotic prescriptions: is prescription sequence symmetry analysis a valid approach?	29
COVID-19 vaccine: missed opportunities and hospital vaccine implementation	29
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study	29
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system	29
How to: improve peer review skills for CMI	29
Sepsis: a summary of the SEP-1 quality measure and future considerations	29
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial	29
Re: ‘Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients’ by Cornely et al.	29
Re: ‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 infection in older Singaporeans’ by Wee et al.	29
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian m	29
Pleural aspergillosis in an otherwise healthy patient diagnosed by medical thoracoscopy	28
ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata	28
Seeing the whole elephant: designing ‘one health’ governance to fight antimicrobial resistance	28
Ceftaroline for methicillin-resistant Staphylococcus aureus bacteraemia: a magic bullet, a weight on the seesaw, or neither?	28
Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China	28
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	27
Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules	27
Management of Gram-positive multiresistant bacteria prosthetic joint infection: a narrative review on current and innovative strategies	27
A contemporary review of clade-specific virological differences in monkeypox viruses	27
The tension between clinical and microbiological relevance in applying clinical trial results for Gram negative bacterial infections	27
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 stud	27
Kinetics of the humoral and cellular immune response up to one year from mpox virus infection	27
Mortality and sequelae associated with regional use of intracranial devices among patients with pneumococcal meningitis: a nationwide, population-based cohort study	27
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model	27
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients	27
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations	26
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains	26
Re: ‘Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard’ by Salzer et al.	26
Target trial emulation framework: mitigating methodological challenges and application in COVID-19 treatment evaluation studies	26
Bacteriophage therapy in humans	26
An open call to join the CMI editorial team: editor in clinical microbiology	26
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	26
Safeguarding COVID-19 vaccines: establishing the safety of novel vaccine platforms	26
Antibiotic use prior to seeking medical care in patients with persistent fever: a cross-sectional study in four low- and middle-income countries	26
Decision letter from other journals and peer review	25
Joint ESCMID, FEMS, IDSA, ISID and SSI position paper on the fair handling of career breaks among physicians and scientists when assessing eligibility for early-career awards	25
Massive furunculoid myiasis in a traveller after a trip to Uganda	25
Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled	25
Sputum proteomic analysis for distinguishing between pulmonary tuberculosis and non-tuberculosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS): prel	25
Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization	25
Corrigendum to “Does SARS-CoV-2 re-infection depend on virus variant?” [Clin Microbiol Infect 27 (9) (2021 Sep) 1374–1375]	25
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection	25
Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: author's response	25
Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study	24
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	24
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review	24
Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination	24
Early and better diagnosis for Lyme neuroborreliosis	24
Refocus attention on HIV/AIDS: due to neglect during the COVID-19 pandemic	24
Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection	24
Factors associated with the detection of norovirus among asymptomatic adults	24
Frequency of and risk factors for reversion of QuantiFERON test in healthcare workers in an intermediate-tuberculosis-burden country	23
Executive Committee	23
Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females	23
Borrelia mayonii – A cause of Lyme borreliosis that can be visualized by microscopy of thin blood films	23
Co-administration of COVID-19 and influenza vaccines	23
Factors associated with the appropriateness of antibiotics prescribed in French general practice: a cross-sectional study using reimbursement databases	23
Widespread circulation of pertussis in Finland during 1968–1972 when the whole cell vaccine was in use	23
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up	23
Corrigendum to “Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model” [Clin Microbiol Infect 29 (12) (2023) P1600.e1–1600.e6]	23
Passive surveillance of Powassan virus in human-biting ticks and health outcomes of associated bite victims	22
Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response	22
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data	22
Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis	22
The challenge to improving and standardizing training in infectious diseases in Europe	22
Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes	22
Case-fatality rate of invasive pneumococcal disease caused by various serotypes—an analysis of nationwide surveillance data from Israel, 2009–2018	22
Enhancing antimicrobial stewardship: recommendations to support implementation of the 2024 UN General Assembly political declaration on antimicrobial resistance	22
Human alveolar echinococcosis–global, regional, and national annual incidence and prevalence rates	22
Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial	22
Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis	22
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series	22
The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study	21
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme	21
Whipple disease: a 15-year retrospective study on 36 patients with positive polymerase chain reaction for Tropheryma whipplei	21
Population pharmacokinetics and dosing simulations of temocillin in liver-transplanted paediatric patients: a prospective, open-label, non-randomized study	21
Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania	21
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	21
HlyF, an underestimated virulence factor of uropathogenic Escherichia coli	21
Duration of immunity after inactivated poliovirus vaccine: how many booster doses are needed?	21
Are antimicrobial stewardship interventions effective and safe in long-term care facilities? A systematic review and meta-analysis	21
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France	21
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	21
Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 – The role of anti-Xa monitoring	21
Reprint of: From medical editors: a call to the global infectious diseases and clinical microbiology community	21
Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational stud	20
The case for the access, watch, and reserve (AWaRe) universal guidelines for antibiotic use	20